Stemming from these observations, we evaluated the impact of N6L on the area of CAFs in mPDAC tumours by an anti-α-SMA staining and observed that α-SMA was strongly reduced in N6L-treated tumours compared with control mice (Figure 4I,J). The gene discussed is ACTA1; the disease is neoplasm.